Between 26 June and 1 July, 570 young scientists and 24 Nobel Laureates will be assembling at Lake Constance to discuss advances in medical research, absorb fresh inspiration and make contacts. With participants from 80 countries, this year’s Lindau Meeting of Nobel Laureates is more international than ever. Many of the young scientists are coming from developing countries where disease is rife - all the more reason, then, to link the Meeting for the first time with a theme “Global Health”.
The young researchers coming to Lindau will also meet Harald zur Hausen who was awarded the Nobel Prize for Medicine in 2008 for his work in identifying human papilloma virus (HPV) as the cause of cervical cancer. The developing countries account for 80 percent of the women who die each year from cervical cancer. Harald zur Hausen is committed to preventing this type of cancer in these regions: “In pilot projects conducted by the Union for International Cancer Control (UICC), for example in Tanzania, we have initiated HPV vaccination programmes in coordination with the local health authorities.”
Microsoft founder Bill Gates will also attend the opening of the 61st Meeting of Nobel Laureates in Lindau (June 26 at 3.00pm/CET). The Foundation Lindau Nobelprizewinners Meetings at Lake Constance will induct him as member of its Honorary Senate. As part of the opening event, Bill Gates will conduct a podium discussion with the young scientists. Bill & Melinda Gates have been supporting global health projects since 1994. “I believe we have the opportunity to make a new future in which global health is the cornerstone of global prosperity,” said Mr Gates recently in explaining his commitment. The Nobel Laureate Meeting concludes on the Island of Mainau with another podium discussion between five prominent representatives of science and politics, which will also focus on global health.
Breaking the vicious circle of poverty and disease
It is predominantly the populations of the developing countries that are at risk of contracting infectious diseases such as malaria, AIDS and tuberculosis. More than a billion people in these regions are also affected by tropical diseases associated with poverty including river blindness, sleeping sickness and dengue fever, which are predominantly caused by parasites. The occurrence of these diseases in the developed world is negligible, which is why efforts to combat them have long been neglected.
Following the Earth Summit in Rio de Janeiro in 1992, however, the realization slowly began to prevail that sustainable development is only possible provided that we are successful in breaking the vicious circle of poverty and disease in emerging nations. Enabling the inhabitants of these regions to access basic medical care has become a global political priority that was confirmed among the Millennium Development Goals adopted by the United Nations in the year 2000. Under the leadership of the WHO, numerous public-private partnerships have been formed in which governments, NGOs, international authorities, private foundations and pharmaceutical companies have joined forces to specifically combat the tropical diseases fostered by poverty. In 2008 almost 670 million people were treated with drugs to address these once neglected illnesses. The WHO nurtures the hope that by 2020 some of these diseases will have been eliminated entirely.
Concentrated aid brings initial successes
This international cooperation is also having an effect in the fight against AIDS, tuberculosis and malaria: in the past decade, the number of cases of HIV infections and the number of deaths from AIDS have declined by around 20 percent. However, for every two patients that are treated, there are still five new cases of infection. Around 63 percent of all those affected in sub-Saharan Africa still have no access to medication. And the majority of young people in the developing countries still do not know enough about AIDS to protect themselves from it.
One in four deaths among immunodeficient AIDS sufferers is due to tuberculosis, which has become particularly dangerous with the emergence of multi-resistant pathogens in the developing nations. Despite this, by 2008 some 86 percent of all tuberculosis patients were treated successfully.
In 25 countries the number of malaria cases has halved since the year 2000. On the one hand, this is due to the protection afforded by impregnated mosquito nets – 289 million of which have been distributed in sub-Saharan Africa alone – and the use of insect sprays in the home. On the other, it is also attributable to improved diagnosis and drug treatments. There are high hopes of a possible protective vaccination against malaria. An initial vaccine is now undergoing clinical trials. If these prove positive, it should be available by 2015.
Decade of Vaccines
The Gates Foundation has been involved in the development of this vaccine. In the year 2000 the Foundation donated 750 million US dollars to support the establishment of the Global Alliance for Vaccines und Immunization (GAVI). Last Monday (13 June) it announced to donate another one billion US dollars to GAVI. This public-private partnership has set itself the goal of providing every child in the developing countries with access to the vaccinations that their contemporaries in the developed world take for granted. The partnership supports developing countries in their negotiations with vaccine manufacturers and promotes the development of new vaccines against pneumonia, meningitis and diarrheal diseases. A year ago, at the Davos Economic Forum, Bill Gates proclaimed a “Decade of Vaccines” and pledged his Foundation to invest ten billion US dollars by 2020 in researching, developing and distributing vaccines: “They are the most effective and cost-effective health tool ever invented.”
The danger of non-transferable diseases is growing
Harald zur Hausen is one of those taking part in the discussion on the outlook for global health, which rounds off the Nobel Laureate Meeting (Friday, July 1/ 11.00am, Isle of Mainau). He will be joined by Unni Karunakara, President of the international aid organisation "Médecins Sans Frontières", which was awarded the Nobel Peace Prize in 1999; Hans Rosling, Professor of International Health at the Karolinska Institute in Stockholm; James W. Vaupel, Director at the Max Planck Institute for Demographic Research in Rostock, and Georg Schütte, Secretary of State at the German Federal Ministry of Education and Research. These five experts will also consider the increasing threat to global health posed by non-transferable diseases, the bulk of which are avoidable insofar as they are often the product of an unhealthy lifestyle. These include cardiovascular diseases, chronic lung diseases, cancer and diabetes. Already these account for almost two thirds of deaths worldwide. And in a trend in which the developing countries are hardest hit, their frequency is increasing. The WHO is therefore urgently calling for greater efforts to be made in education and prevention. For some countries already grappling with infectious diseases, WHO Director General Margaret Chan recently declared that the spread of these chronic non-transferable diseases constitutes “an impending disaster: a disaster for health, for society, and most of all for national economies.”
“I believe we have the opportunity to make a new future in which global health is the cornerstone of global prosperity.” (Bill Gates, 17 May 2011)
“They are the most effective and cost-effective health tool ever invented.” (Gates Foundation, 2011 Annual Letter from Bill Gates, page 9)
“For some countries, it is no exaggeration to describe the situation as an impending disaster; a disaster for health, for society, and most of all for national economies." (Margaret Chan, 27 April 2011)
Opening Ceremony and Accreditation:
The opening ceremony takes place on June 26, 2011 at 3.00pm /CET at the Inselhalle at Lindau/Germany. It will be streamed live on www.lindau-nobel.org. If you like to register for the opening ceremony/ the meeting please go to: http://www.lindau-nobel.org/Accreditation.AxCMS?ActiveID=1224Programme:
ASEAN Member States discuss the future role of renewable energy
17.10.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
World Health Summit 2017: International experts set the course for the future of Global Health
10.10.2017 | World Health Summit
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
17.10.2017 | Life Sciences
17.10.2017 | Life Sciences
17.10.2017 | Earth Sciences